ResMed | RMD - Ebitda



ResMed reported $540.03M in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Ansell USD 175.2M 60.8M Jun/2024
AtriCure USD 15.35M 16.22M Jun/2025
Baxter International USD 325M 251M Mar/2025
Cochlear AUD 323M 24.1M Dec/2024
Cooper Companies USD 272.7M 5.8M Jul/2025
CSL USD 3.23B 1.52B Dec/2024
Dexcom USD 308.8M 115.1M Jun/2025
Edwards Lifesciences USD 411.3M 15.3M Mar/2025
Fisher Paykel Healthcare NZD 654.3M 378.6M Mar/2025
Globus Medical USD 208.68M 44.48M Jun/2025
Haemonetics USD 106.31M 6.77M Jun/2025
Hologic USD 334M 26.7M Jun/2025
Idexx Laboratories USD 409.44M 58.85M Jun/2025
Insulet USD 157.5M 47M Jun/2025
Integra LifeSciences USD -472218000 536.09M Jun/2025
Intuitive Surgical USD 898.7M 317.2M Jun/2025
Masimo USD 72M 17.3M Jun/2025
Medtronic USD 2.31B 400M Jul/2025
Philips EUR 747M 174M Jun/2025
Ramsay Health Care AUD 1.02B 22.3M Dec/2024
ResMed USD 540.03M 61.85M Jun/2025
Sigma Healthcare AUD 19.96M 5.15M Jul/2024
Sonic Healthcare AUD 839.07M 51.09M Dec/2024
Steris USD 353.78M 33.81M Mar/2025
Teleflex USD 222.67M 27.85M Jun/2025
Thermo Fisher Scientific USD 3.06B 541M Jun/2025